Target intelligence / Profile preview

Splicing factor proline and glutamine rich pseudogene 1 (SFPQP1)

Target: SFPQP1
Molecular classification: Other (pseudogene)

Overview

SFPQP1 is annotated as a pseudogene related to the splicing factor proline and glutamine rich (SFPQ) protein[7][9][3][5][1]. Unlike SFPQ, which participates in pre-mRNA splicing, transcriptional regulation, DNA repair, and paraspeckle formation, SFPQP1 does not encode a functional protein and is therefore not considered a therapeutic target. Its classification as a pseudogene means it is a gene sequence similar to SFPQ, likely originating from a duplication or retrotransposition event, but it does not produce an active product and has no confirmed functional role[7][9][3].

Other names: SFPQPSplicing factor proline and glutamine rich pseudogene 1

Beyond the preview

Go deeper on Splicing factor proline and glutamine rich pseudogene 1 (SFPQP1).

Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.

Drug pipeline

Explore the programs pursuing this target and their development progress.

Drug candidates
Developers
Development stage

Clinical trials

Follow the clinical studies evaluating therapies directed at this target.

Trial design
Status
Readouts

Competitive landscape

Compare approaches across drug candidates, modalities, and indications.

Programs
Modalities
Indications

Literature & evidence

Investigate the research and source evidence behind target biology and development.

Publications
Sources
Analysis

Patents

Explore patent activity around therapies and technologies addressing this target.

Patents
Assignees
Technologies

Research & analysis

Connect target biology, drug development, and emerging evidence in your research.

Biology
Development news
Analysis

Bring the full picture into focus.

See how Gosset can support your research on Splicing factor proline and glutamine rich pseudogene 1 (SFPQP1).

Explore the full profile